You just read:

Key Patent is Issued Covering Protagonist Therapeutics' Alpha4Beta7 Integrin Peptide Inhibitors including Oral Drug Candidate PTG-100

News provided by

Protagonist Therapeutics, Inc.

Jan 05, 2017, 08:00 ET